Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study

Blood Cancer Journal, Published online: 18 January 2024; doi:10.1038/s41408-024-00982-3Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study

Source: Blood Cancer Journal - January 18, 2024 Category: Hematology Authors: Yan-Yan Li Shuai-Shuai Ge Yuan-Hong Huang Ming-Zhu Xu Chao-Ling Wan Kai-Wen Tan Tao Tao Hai-Xia Zhou Sheng-Li Xue Hai-Ping Dai Source Type: research